ITGAX and Hyperglycemia: Our data suggest that the absence of autophagy in hepatic CD11c+ cells results in increased weight gain, fasting hyperglycemia, insulin insensitivity, glucose intolerance, hepatomegaly, liver inflammation, and steatosis when compared to control mice.